Curi Bio Names Nicholas A. Geisse, Ph.D., as New Chief Executive Officer
Dr. Geisse brings 15 years of life science experience after having led scientific strategy for Curi Bio since 2017.SEATTLE--(BUSINESS WIRE)--#BioTech--Curi Bio, a leading developer of human stem cell-based platforms for drug discovery, today announced the appointment of Nicholas A. Geisse, Ph.D. as Chief Executive O...
Source: pharmiweb.com